55 Low frequency of breast cancer recurrence following introduction of adjuvant trastuzumab in HER-2 positive early breast cancer: an audit of relapses in a UK Cancer Centre and the implications for future practice
S. Haney, P. Stephens, P. Gamble, M. VerrillVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70086-0
File:
PDF, 64 KB
english, 2010